The effect of vitamin D supplementation on markers of insulin resistance in women with polycystic ovarian syndrome: a systematic review
European Journal of Nutrition · 2024-12 · 63 (8) · 2859-2869
DOI: 10.1007/s00394-024-03489-6 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift European Journal of Nutrition, online erschienen am 14.09.2024. Verfasst von Georgia Kohlhoff und 2 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, Dentistry and Life Sciences, University of Chester, Chester, UK. Hauptthemen laut MEDLINE: Biomarkers, Dietary Supplements, Insulin Resistance, Polycystic Ovary Syndrome. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Insulin resistance (IR) is a common pathology in women with polycystic ovarian syndrome (PCOS) involved in increased rates of cardiometabolic disease such as diabetes and cardiovascular disease. Low serum vitamin D is often associated with insulin resistance but there is no consensus on whether vitamin D supplementation can ameliorate markers of IR in PCOS.
Objectives
We assessed evidence on the effects of vitamin D supplementation (≥ 1000 IU/day), without the use of additional supplements or other pharmacological treatments known to affect IR, on markers of IR and glycemic control in women with PCOS.
Design
A systematic search was conducted using PubMed, Medline and Web of Science databases from January 2000 up to November 2023. Randomized controlled trials that assessed the effects of vitamin D supplementation in women with PCOS, on fasting glucose, fasting insulin, glycated haemoglobin (HbA1c) or homeostatic model assessment for insulin resistance (HOMA-IR) were included.
Results
9 studies were identified. Study populations ranged from 28 to 180 participants, with mean ages ranging from 22 to 30 years. Daily vitamin D doses ranged from 1714-12,000 IU. Of the included studies, 3 reported statistically significant reductions in fasting glucose, 2 reported reductions in fasting insulin, 2 reported reductions in HOMA-IR, none reported reductions in HbA1c and 5 reported no differences in any of the relevant outcomes.
Conclusions
In conclusion, in RCTs of vitamin D supplementation in women with PCOS, the majority of studies do not report statistically significant improvements in fasting glucose, fasting insulin, HbA1c or HOMA-IR. However, as a minority of studies report some statistically significant results, further investigation may be warranted. Registry PROSPERO ID: CRD42023486144
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Medicine, Dentistry and Life Sciences, University of Chester, Chester, UK.
- Research Institute for Sport and Exercise Sciences, Liverpool John Moores University, Liverpool, UK. r.p.kirwan@ljmu.ac.uk.
Zitieren
APA
Kohlhoff, G., Kirwan, R., & Mushtaq, S. (2024). The effect of vitamin D supplementation on markers of insulin resistance in women with polycystic ovarian syndrome: a systematic review. European Journal of Nutrition, 63(8), 2859-2869. https://doi.org/10.1007/s00394-024-03489-6
Vancouver
Kohlhoff G, Kirwan R, Mushtaq S. The effect of vitamin D supplementation on markers of insulin resistance in women with polycystic ovarian syndrome: a systematic review. European Journal of Nutrition. 2024;63(8):2859-2869. doi:10.1007/s00394-024-03489-6
BibTeX
@article{Kohlhoff2024,
author = {Kohlhoff, Georgia and Kirwan, Richard and Mushtaq, Sohail},
title = {The effect of vitamin D supplementation on markers of insulin resistance in women with polycystic ovarian syndrome: a systematic review},
journal = {European Journal of Nutrition},
year = {2024},
volume = {63},
number = {8},
pages = {2859--2869},
doi = {10.1007/s00394-024-03489-6}
}
EUVIMED